Spencer Z. Rosero
Direttore Tecnico/Scientifico/R&S presso Efferent Labs, Inc.
Profilo
Spencer Z.
Rosero is the founder of Physiologic Communications LLC, founded in 2004.
He is currently the Director & Chief Medical Officer at Efferent Labs, Inc. and a Professor at the University of Rochester.
Posizioni attive di Spencer Z. Rosero
| Società | Posizione | Inizio |
|---|---|---|
| Rochester Christian University | Corporate Officer/Principal | - |
Efferent Labs, Inc.
 Efferent Labs, Inc. BiotechnologyHealth Technology Efferent Labs, Inc. operates as a preclinical stage biotechnology company. The firm focuses on implantable biosensors for life sciences. Its CytoComm biosensor platform has multiple applications including preclinical R&D, clinical testing, oncology, cardiology, and metabolic diseases. The company was founded by William K. Rader and is headquartered in Buffalo, NY. | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Spencer Z. Rosero
| Società | Posizione | Fine |
|---|---|---|
Physiologic Communications LLC
 Physiologic Communications LLC Medical SpecialtiesHealth Technology Physiologic Communications LLC designs and develops implantable electronic devices. It offers implantable wireless biosensors that integrate living cells and a tool to monitor biochemical signals. The company was founded by Spencer Z. Rosero on July 12, 2004 and is headquartered in Rochester, NY | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Physiologic Communications LLC
Physiologic Communications LLC Medical SpecialtiesHealth Technology Physiologic Communications LLC designs and develops implantable electronic devices. It offers implantable wireless biosensors that integrate living cells and a tool to monitor biochemical signals. The company was founded by Spencer Z. Rosero on July 12, 2004 and is headquartered in Rochester, NY | Health Technology |
Efferent Labs, Inc.
Efferent Labs, Inc. BiotechnologyHealth Technology Efferent Labs, Inc. operates as a preclinical stage biotechnology company. The firm focuses on implantable biosensors for life sciences. Its CytoComm biosensor platform has multiple applications including preclinical R&D, clinical testing, oncology, cardiology, and metabolic diseases. The company was founded by William K. Rader and is headquartered in Buffalo, NY. | Health Technology |
- Borsa valori
- Insiders
- Spencer Z. Rosero
